Sagent Pharmaceuticals, Inc. (Nasdaq: SGNT) today announced the launch of Vancomycin Hydrochloride for Injection, USP, an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE